CD44 and non-small cell lung carcinoma: Analysis of a spatial transcriptomic database of NSCLC BrM 32 also demonstrated that the spatial intra- and peri-tumoral regions of metastases with high CD44 expression had significantly higher expression of CD146 compared with regions with low CD44 expression (Figure 1I).